Navigation Links
Biogas Consortium Using Genedata Selector for Metagenomics-based Process Optimization

Munich, Germany (PRWEB) November 19, 2013

Genedata, a leading provider of advanced software solutions for industrial biotechnology, drug discovery, and life science research, today announced its collaboration with GOBI (“General Optimization of BIogasprocesses”), an interdisciplinary biogas research consortium consisting of leading academic and commercial members to improve the overall efficiency of biogas production. GOBI will be using Genedata Selector to leverage the analysis of high-throughput sequencing data, gene expression data, and genotype-phenotype relationships to optimize their biogas fermentation processes. In addition, this collaboration will provide a centralized knowledge management and analysis platform for the different consortium members. More information about the GOBI project and about how Genedata Selector supports industrial biotechnology and renewable energy workflows will be presented at the 5th Annual Next-Generation Sequencing Conference (November 18-19, London).

"Biologically derived methane – biogas – plays an important role in meeting global energy demands. At the molecular level, the underlying fermentation process is still considered a black box. ” noted GOBI project coordinator Prof. Dr. Joachim Müller (Institute of Agricultural Engineering, University of Hohenheim). “ Understanding this complex process at this level promises a huge optimization potential to increase production yield and diversification such as leveraging waste streams of organic acids for higher value products, specialized fertilizers and sustainable waste management."

“A full understanding of the complete molecular processes in order to optimize microbe populations requires the interpretation of large volumes of complex DNA data representing diverse microbial genomes and strains as well as their RNA data to resolve the transcriptional profile and activities along the fermentation process” said Dr. Steffen Rupp, Head of Department of Molecular Biotechnology at Fraunhofer IGB Stuttgart. He added “Genedata provides us with a comprehensive, collaborative and secure platform for data management and a central database for proprietary and public sequence data. Beyond that, it gives us bioinformatics tools for next-generation sequencing data analyses, taxonomic profiling of microbial communities, and de-novo discovery of genes, proteins and pathways in biomass degradation.”

Empowering Industrial Biotech R&D
The GOBI project, funded by the German Federal Ministry of Education and Research, demonstrates the efficacy of Genedata Selector as an enterprise-ready platform that empowers research across the entire R&D workflow for industrial biotechnology. It supports NGS-based genome analyses and the complete mapping of sequence, omics, pathway, and phenotype data. Specifically, the system provides GOBI with:

  • Full support of bioprocess engineering: from metagenomics, biomass to microbiome analysis
  • Integrative, scalable, and secure strain management
  • Complete set of software tools including analyses of raw sequencing data, omics data, and statistics
  • Strain analyses tools to optimize feedstock and use of starter cultures in the fermentation process
  • Decision support for production of biogas and bio-based materials

“Genedata is excited to partner with the GOBI consortium and have Genedata Selector contribute to advancing research into renewable energy sources,” said Dr Othmar Pfannes, CEO of Genedata. “The work with GOBI has applications beyond biogas production, and is an important piece of our strategy to position Genedata Selector as the platform of choice for innovative bio-based products in industries spanning consumer care and cosmetics to fertilizers and feedstock.”

About Genedata
Genedata transforms data into intelligence with a portfolio of advanced software solutions, which make research data accessible and understandable and research processes more efficient. These solutions are used worldwide by leading pharmaceutical, industrial, and agricultural biotechnology companies as well as academic research organizations. Genedata innovations enable scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Germany, Japan, and the US.

About the Research Project GOBI
GOBI (General Optimization of BIogasprocesses) is an interdisciplinary German biogas research consortium to improve the overall efficiency of biogas production. The project is funded by the German Federal Ministry of Education and Research (BMBF) as part of the program “BioProFi – Bioenergie – Prozessorientierte F&I”. The consortium consists of the following institutes: Agricultural Engineering in the tropics and subtropics; Fertilisation and Soil Matter Dynamics; Biobased Products and Energy Crops; State Institute of Agricultural Engineering and Bioenergy; and Fraunhofer IGB; IS-Forschung Pinneberg; Geltz-Umwelttechnologie GmbH; Agentur für nachhaltige Nutzung von Agrarlandschaften (ANNA); and Genedata

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. VolitionRx-led Consortium Awarded euro 780 000 ($1M approx.) Eurostars Grant
2. Elsevier Announces its Collaboration with Hungarian National Consortium
3. Pfizer, GSK, and Siemens Form R&D Consortium With A*STARs Institute of Chemical & Engineering Sciences
4. Herbal Quality Consortium Publishes Major Article on Black Cohosh Adulteration
5. Elekta and Philips Gain MD Anderson Cancer Center as Collaborator in Research Consortium on MRI-Guided Radiation Therapy
6. Some Bilberry Fruit Extracts Adulterated, says Nonprofit Research Consortium
7. Tel Aviv University to spearhead groundbreaking nanotechnology consortium
8. JCVI Researchers, as Part of NIH Human Microbiome Project Consortium, Publish Papers Detailing the Variety and Abundance of Microbes Living on and in the Human Body
9. Pharmaceutical Consortium Selects BioFortis Software to Manage Collaborative Clinical Data and Biobanking Activities
10. Nonprofit Consortium Publishes Review of Skullcap Adulteration
11. Quantitative Profiling of the Intrinsic Pathway of Apoptosis in Tumor Tissue Using Myriad RBM’s Multiplex ApoptosisMAP™, a New Biomarker Webinar by Xtalks
Post Your Comments:
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche ... with peritoneal or pleural mesothelioma. Their findings are the subject of a new article ... Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients ...
(Date:6/23/2016)... WI (PRWEB) , ... June 23, 2016 , ... ... supplements, is pleased to announce the launch of their brand, UP4™ Probiotics, into ... for over 35 years, is proud to add Target to its list of ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... , June 23, 2016 Houston ... with the Cy-Fair Sports Association to serve as ... the agreement, Houston Methodist Willowbrook will provide sponsorship ... and connectivity with association coaches, volunteers, athletes and ... with the Cy-Fair Sports Association and to bring ...
Breaking Biology Technology:
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):